Kogenate: A recombinant technology-derived human antihemophilic factor (FVIII) concentrate

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Cite this

@article{fa2b49bbe872428196e355b2d95b0623,

title = "Kogenate: A recombinant technology-derived human antihemophilic factor (FVIII) concentrate",

author = "S. Arkin and Aledort, \{L. M.\}",

year = "1995",

language = "English",

volume = "31",

pages = "173--183",

journal = "Drugs of Today",

issn = "1699-3993",

publisher = "Clarivate",

number = "3",

}